Render Target: STATIC
Render Timestamp: 2025-03-19T10:55:56.590Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:19:35.832
Product last modified at: 2025-01-07T20:45:09.827Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

DNA Ligase III (F2A1H) Rabbit mAb #43640

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 100
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Simple Western™ 1:10 - 1:50
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    DNA Ligase III (F2A1H) Rabbit mAb recognizes endogenous levels of total DNA ligase III protein.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human DNA ligase III protein.

    Background

    DNA ligase III/LIG3 is an ATP-dependent DNA ligase that functions in DNA repair. Four isoforms of LIG3 result from alternative splicing/initiation, including a mitochondrial-specific isoform essential for cell viability (1). Loss of nuclear LIG3 sensitizes resistant cells to PARP inhibitors and enhances PARP inhibitor efficacy in BRCA1-deficient mouse mammary tumors (2). In multiple myeloma (MM), LIG3 is crucial for repair of DNA double-stranded breaks (DSBs) via alternative-non-homologous end joining (Alt-NHEJ), and LIG3 inhibitors are being investigated as cancer therapeutics (3).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.